Two Sigma Investments, LP Eagle Pharmaceuticals, Inc. Transaction History

Two Sigma Investments, LP

$42.3 Billion
Q3 2024

A detailed history of Two Sigma Investments, LP transactions in Eagle Pharmaceuticals, Inc. stock. As of the latest transaction made, Two Sigma Investments, LP holds 119,312 shares of EGRX stock, worth $62,042. This represents 0.0% of its overall portfolio holdings.

Number of Shares

119,312

Previous 133,944 10.92%

Holding current value

$62,042

Previous $750,000 41.07%

% of portfolio

0.0%

Previous 0.0%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$3.71 - $6.07 $54,284 - $88,816	-14,632 Reduced 10.92%	119,312 $442,000
Q2 2024 Aug 14, 2024	SELL	$3.34 - $5.6 $98,499 - $165,149	-29,491 Reduced 18.04%	133,944 $750,000
Q1 2024 May 15, 2024	SELL	$4.26 - $6.51 $188,202 - $287,605	-44,179 Reduced 21.28%	163,435 $856,000
Q4 2023 Feb 14, 2024	BUY	$4.63 - $15.21 $809,944 - $2.66 Million	174,934 Added 535.29%	207,614 $1.09 Million
Q3 2023 Nov 14, 2023	BUY	$15.21 - $22.88 $54,390 - $81,818	3,576 Added 12.29%	32,680 $515,000
Q2 2023 Aug 14, 2023	BUY	$17.74 - $31.87 $516,304 - $927,544	29,104 New	29,104 $565,000
Q2 2021 Aug 16, 2021	SELL	$36.86 - $44.5 $4.69 Million - $5.66 Million	-127,206 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.32 - $50.97 $867,847 - $1.1 Million	21,524 Added 20.37%	127,206 $5.31 Million
Q4 2020 Feb 16, 2021	BUY	$41.72 - $51.34 $2.23 Million - $2.74 Million	53,409 Added 102.17%	105,682 $4.92 Million
Q3 2020 Nov 16, 2020	BUY	$37.02 - $51.28 $648,183 - $897,861	17,509 Added 50.37%	52,273 $2.22 Million
Q2 2020 Aug 14, 2020	BUY	$43.24 - $55.02 $1.5 Million - $1.91 Million	34,764 New	34,764 $1.67 Million
Q2 2019 Aug 14, 2019	SELL	$46.61 - $58.45 $4.52 Million - $5.67 Million	-97,049 Closed	0 $0
Q1 2019 May 15, 2019	BUY	$38.66 - $51.82 $146,482 - $196,345	3,789 Added 4.06%	97,049 $4.9 Million
Q4 2018 Feb 14, 2019	BUY	$36.72 - $67.73 $3.42 Million - $6.32 Million	93,260 New	93,260 $3.76 Million
Q3 2018 Nov 14, 2018	SELL	$66.65 - $83.86 $3.19 Million - $4.02 Million	-47,901 Closed	0 $0
Q2 2018 Aug 14, 2018	BUY	$51.25 - $76.62 $2.45 Million - $3.67 Million	47,901 New	47,901 $3.62 Million

Others Institutions Holding EGRX

# of Institutions

Shares Held

8.6M

Call Options Held

Put Options Held

100

View Full List

About EAGLE PHARMACEUTICALS, INC.

Ticker EGRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 13,015,900
Market Cap $6.77M
Description
Eagle Pharmaceuticals, Inc., a pharmaceutical company, focuses on developing and commercializing product candidates to treat diseases of the central nervous system or metabolic critical care, and oncology in the United States. The company offers Ryanodex for malignant hyperthermia; and Belrapzo and Bendeka for chronic lymphocytic leukemia and in...

More about EGRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Two Sigma Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Two Sigma Investments, LP with notifications on news.

Account

Two Sigma Investments, LP Eagle Pharmaceuticals, Inc. Transaction History